DeCure's autonomous Rare AI scientist is researching a drug-repurposing hypothesis for Scheuermann disease — screening already-approved drugs against its 1-gene Open Targets disease module to publish open-access research. Research is fast; the path to publication is funded in milestone stages.
Disease moduleScheuermann disease maps to a 1-gene Open Targets module — the target space DeCure's AI scientist screens approved drugs against.
DeCure.ai methodSignature reversal (LINCS) plus network proximity (STRING) rank already-approved drugs likely to perturb this module — the same engine that produces DeCure.ai's repurposing hypotheses.
Repurposing thesisScreening approved medicines against this disease module, then publishing the evidence for the strongest candidate. Known pharmacology and human exposure data make the first question sharper — they do not establish safety or efficacy in a new indication.
Research record
01
ResearchComing soon
Candidate research + dossier — target rationale, drug-repurposing thesis and evidence pack.proof: Published dossier + on-chain hash
02
ValidationComing soon
In-vitro biological validation at a contract research org (CRO).proof: CRO contract + in-vitro report
03
Peer review & paperComing soon
Peer-reviewed paper published open-access (preprint + journal).proof: DOI + open-access link + on-chain hash
Current lead
No approved-drug candidate for scheuermann disease is corroborated in the literature DeepSearch retrieved. Some conditions are managed with non-pharmacological care — a device, surgery or physical therapy — rather than a medicine; that may be the case here, or the literature we found may simply be too sparse yet to support a drug-repurposing angle.
Molecular view
N-acetylglucosamine-1-phosphate transferase subunits alpha and beta (GNPTAB) — GNPTAB is one of the genes genetically linked to this disease in Open Targets — shown as context, not as a drug target we're pursuing: no approved-drug candidate for this disease is yet corroborated in the literature we found.
Loading structure…
helix sheet ud1drag to rotate · scroll to zoom
RCSB Protein Data Bank · entry 9BGF · 2.9 Å · ligand URIDINE-DIPHOSPHATE-N-ACETYLGLUCOSAMINE (UD1). Experimental structure, not a prediction.
What the evidence adds up to
A 2002 report of male monozygotic twins found Scheuermann disease at the same vertebral levels in both, with Cobb angles of 74 degrees and 48 degrees. Neither parent showed kyphotic abnormality. The authors concluded these cases support a genetic contribution, consistent with an earlier hypothesis of autosomal dominant inheritance. The sample is two patients.
A 2023 case report describes a 24-year-old man with diffuse idiopathic skeletal hyperostosis (DISH) co-existing with Scheuermann disease and thoracic spinal stenosis. He presented with low back pain and bilateral lower limb numbness. After laminectomy with internal fixation, he received corticosteroids, neurotrophic drugs, hyperbaric oxygen, and electric stimulation. His sensory level dropped from below the xiphoid process to the navel, and lower limb muscle strength did not change. At follow-up, skin sensation had returned to normal. This is a single case; no generalisable treatment effect can be drawn.
A 2016 textbook chapter reviews imaging, differential diagnosis, clinical presentation, and management of Scheuermann disease but provides no new data or trial results.
No drug is mentioned in any abstract as a treatment for Scheuermann disease itself. The 2023 case used corticosteroids and neurotrophic drugs post-operatively, but the report does not isolate their effect from surgery or other interventions. What is missing: any controlled trial of a drug for Scheuermann disease, any patient stratification by genetic or radiographic subtype, and any funding for such research.
Evidence
Retrieved by DeepSearch across 234,678,978 indexed works and resolved on OpenAlex — ranked by citations, including the results that did not work.
Spine · 2002 · 48 citations
Classical Scheuermann Disease in Male Monozygotic Twins
AbstractSTUDY DESIGN: Classic cases of Scheuermann disease in male monozygotic twins are reported. OBJECTIVES: To report classic cases of Scheuermann disease or Scheuermann kyphosis in male monozygotic twins, and to discuss the previous two cases of classic Scheuermann disease in monozygotic twins and the genetic etiology theory of Scheuermann kyphosis. SUMMARY OF BACKGROUND DATA: The etiology of Scheuermann disease remains unclear. Both genetic and mechanical factors or a combination of the two have been postulated to explain Scheuermann disease. The genetic etiology hypothesis has been explained by an autosomal dominant inheritance pattern. In support of this genetic etiology hypothesis, two cases of Scheuermann disease in monozygotic twins have been reported in the English literature. METHODS: The criteria of Sørensen and Sachs et al were used to diagnose Scheuermann kyphosis. Clinical examination and lateral spinal radiographs were performed on a male monozygotic twin. Both parents were clinically investigated for signs of a kyphotic deformity. RESULTS Scheuermann disease was noted in both patients at the same vertebral levels. The Cobb angle of the kyphosis was 74 degrees and 48 degrees, respectively. Clinical examination of both parents did not show any kyphotic abnormality. CONCLUSIONS: These cases of classic Scheuermann disease in monozygotic male twins support the theory that there is a genetic contribution in classic Scheuermann disease.
World Journal of Clinical Cases · 2023 · 3 citations · open access
Young thoracic vertebra diffuse idiopathic skeletal hyperostosis with Scheuermann disease: A case report
AbstractBACKGROUND: Diffuse idiopathic skeletal hyperostosis (DISH) is a disorder characterised by the calcification and ossification of ligaments and entheses. It is a frequent occurrence in elderly males, but rarely encountered in younger individuals. CASE SUMMARY: A 24-year-old male was admitted to the hospital due to low back pain accompanied with numbness in both lower limbs for 10 d. Upon clinical examination and imaging tests, the patient was diagnosed with DISH with Scheuermann disease and thoracic spinal stenosis. Before the operation and medical treatment, the patient had hypoesthesia of the skin below the xiphoid process. Afterward, a standard laminectomy was conducted using ultrasonic bone curette and internal fixation was applied. Subsequently, the patient was given corticosteroids, neurotrophic drugs, hyperbaric oxygen and electric stimulation. As a result of the treatment, the patient's sensory level decreased to the navel level and there was no major change in the muscle strength of the lower limbs. During follow-up, the patient's skin sensation has returned to normal. CONCLUSION: This case is a rare instance of DISH co-existing with Scheuermann's disease in a young adult. This provides a valuable reference point for spine surgeons, as DISH is more commonly observed in middle-aged and elder adults.
Oxford University Press eBooks · 2016 · 0 citations
Chapter 78
AbstractAbstract This chapter describes a case of a patient with Scheuermann disease. The case reviews the imaging findings, differential diagnosis, clinical presentation, etiology, and imaging workup of Scheuermann disease. A brief discussion is also made of the clinical management. Key learning points are highlighted.
Disease module: DeepOracle (Open Targets). Structures: RDKit from PubChem SMILES. Literature: retrieved by DeepSearch across 234,678,978 indexed works (targeted per-candidate search), resolved on OpenAlex.
DeCure is a research and publication project, not medical advice and not a treatment. "DeCure for X" describes a research goal, not a claim that a cure exists. Backing a cure is a contribution to fund the research — it is not an investment, and confers no yield, royalty, equity or IP ownership. Papers are published open-access by the DeCure.ai DAO.
